Post Categories
Early Alzheimer’s Patients Benefit from Leqembi
Like many neurodegenerative diseases, early diagnosis and treatment of Alzheimer’s disease (AD) can greatly improve quality of life for individuals with the disease. Now,…

Early Alzheimer’s Patients Benefit from Leqembi
November 13, 2024
Like many neurodegenerative diseases, early diagnosis and treatment of Alzheimer’s disease (AD) can greatly improve quality of life for individuals with the disease. Now,…
Sounding Out Disease: Using AI to Help Close the Diagnosis Gap for Millions with Tuberculosis
With millions of tuberculosis (TB) cases left undiagnosed each year due to limited healthcare access or incorrect diagnoses, researchers are turning to artificial intelligence…

Sounding Out Disease: Using AI to Help Close the Diagnosis Gap for Millions with Tuberculosis
November 11, 2024
With millions of tuberculosis (TB) cases left undiagnosed each year due to limited healthcare access or incorrect diagnoses, researchers are turning to artificial intelligence…
Rezdiffra Gains Approval, Marks a New Chapter in Treating NASH (MASH) with Liver Scarring
The US Food and Drug Administration (FDA) has approved Rezdiffra™ (resmetirom), the first medication for treating patients with nonalcoholic steatohepatitis (NASH) with moderate to…

Rezdiffra Gains Approval, Marks a New Chapter in Treating NASH (MASH) with Liver Scarring
November 4, 2024
The US Food and Drug Administration (FDA) has approved Rezdiffra™ (resmetirom), the first medication for treating patients with nonalcoholic steatohepatitis (NASH) with moderate to…
Exciting New Epilepsy Drug Reduces Seizures
Epilepsy affects as many as 50 million people worldwide, with a broad range of disease subtypes with limited treatment options. Fortunately, a new epilepsy…

Exciting New Epilepsy Drug Reduces Seizures
October 30, 2024
Epilepsy affects as many as 50 million people worldwide, with a broad range of disease subtypes with limited treatment options. Fortunately, a new epilepsy…
Could Gene Therapy in Cows Slow Climate Change?
Despite the impact of companies like Impossible Foods, which markets plant-based imitation meat products, the demand for beef has never been higher. As of…

Could Gene Therapy in Cows Slow Climate Change?
October 28, 2024
Despite the impact of companies like Impossible Foods, which markets plant-based imitation meat products, the demand for beef has never been higher. As of…
Weight Loss Drug Prescriptions Become More Accessible With Single-Dose Option
Eli Lilly has launched a new way for patients to access its popular weight loss drug, Zepbound® (tirzepatide). The company now offers single-dose vials…

Weight Loss Drug Prescriptions Become More Accessible With Single-Dose Option
October 21, 2024
Eli Lilly has launched a new way for patients to access its popular weight loss drug, Zepbound® (tirzepatide). The company now offers single-dose vials…
Sizing Up Potential Medicare Costs of Covering Weight Loss Drugs for Heart Health
Medicare may soon face steeply increased prescription drug costs as it considers covering the popular weight loss drug, Wegovy® (semaglutide). Known for its ability…

Sizing Up Potential Medicare Costs of Covering Weight Loss Drugs for Heart Health
October 14, 2024
Medicare may soon face steeply increased prescription drug costs as it considers covering the popular weight loss drug, Wegovy® (semaglutide). Known for its ability…
Bispecific Antibody Drug Shows Cancer Treatment Potential
A new contender in the fight against lung cancer has emerged, with strong clinical trial results for ivonescimab, a bispecific antibody from partners Akeso…

Bispecific Antibody Drug Shows Cancer Treatment Potential
October 7, 2024
A new contender in the fight against lung cancer has emerged, with strong clinical trial results for ivonescimab, a bispecific antibody from partners Akeso…
Advancing CRISPR-Based Treatment for Rare Swelling Disease
Intellia Therapeutics, based in Cambridge, Massachusetts, reported promising results from the Phase II clinical trial of NTLA-2002, a CRISPR-based therapy targeting hereditary angioedema (HAE),…

Advancing CRISPR-Based Treatment for Rare Swelling Disease
September 30, 2024
Intellia Therapeutics, based in Cambridge, Massachusetts, reported promising results from the Phase II clinical trial of NTLA-2002, a CRISPR-based therapy targeting hereditary angioedema (HAE),…
Advancing Phase 3 Trials for ADC Cancer Therapies
Antibody-drug conjugates (ADCs) are being studied in various diseases, including cancer, autoimmune and infectious diseases. In cancer, ADCs are made up of a monoclonal…

Advancing Phase 3 Trials for ADC Cancer Therapies
September 25, 2024
Antibody-drug conjugates (ADCs) are being studied in various diseases, including cancer, autoimmune and infectious diseases. In cancer, ADCs are made up of a monoclonal…
Battling COVID in the Lab: Mini-Lungs Yield Insights and Potential Prevention Pathways
Over the past five years, scientists have slowly gained a better understanding of SARS-CoV-2, the virus responsible for the COVID-19 pandemic. Despite our knowledge…

Battling COVID in the Lab: Mini-Lungs Yield Insights and Potential Prevention Pathways
September 23, 2024
Over the past five years, scientists have slowly gained a better understanding of SARS-CoV-2, the virus responsible for the COVID-19 pandemic. Despite our knowledge…
New Cancer Treatment Modality Goes into Phase I
Prostate cancer is the second most common cancer in men worldwide, making the search for effective treatments an urgent imperative for the medical community….

New Cancer Treatment Modality Goes into Phase I
September 18, 2024
Prostate cancer is the second most common cancer in men worldwide, making the search for effective treatments an urgent imperative for the medical community….
An Unintended Consequence of Intermittent Fasting: Reduced Hair Growth
Intermittent fasting is quickly becoming one of the most popular dietary adjustments around the world. Less of a “diet” and more of a “dietary…

An Unintended Consequence of Intermittent Fasting: Reduced Hair Growth
January 15, 2025
Intermittent fasting is quickly becoming one of the most popular dietary adjustments around the world. Less of a “diet” and more of a “dietary…
Encouraging Preclinical Results Show Gene Therapy Reduces Seizures
California-based Capsida Biotherapeutics has reported promising preclinical results for CAP-002, its gene therapy for developmental and epileptic encephalopathy (DEE) caused by mutations in the…

Encouraging Preclinical Results Show Gene Therapy Reduces Seizures
January 13, 2025
California-based Capsida Biotherapeutics has reported promising preclinical results for CAP-002, its gene therapy for developmental and epileptic encephalopathy (DEE) caused by mutations in the…
The Role of Fungi in Absorbing and Transferring Carbon
Travel to southwest London, and you’ll have the opportunity to visit Kew Gardens, a stunning botanical collection founded in 1840. The complex includes a…

The Role of Fungi in Absorbing and Transferring Carbon
December 16, 2024
Travel to southwest London, and you’ll have the opportunity to visit Kew Gardens, a stunning botanical collection founded in 1840. The complex includes a…
Why Do Dogs Wag Their Tails So Much?
Dogs have been man’s best friend since they were first domesticated thousands of years ago. A friendly bark, a comforting nuzzle — dogs find…

Why Do Dogs Wag Their Tails So Much?
December 4, 2024
Dogs have been man’s best friend since they were first domesticated thousands of years ago. A friendly bark, a comforting nuzzle — dogs find…
New Antibiotic Could Simplify Gonorrhea Treatment
Gonorrhea is one of the most widespread sexually transmitted infections, with as many as 82 million new infections occurring worldwide each year. While not…

New Antibiotic Could Simplify Gonorrhea Treatment
November 20, 2024
Gonorrhea is one of the most widespread sexually transmitted infections, with as many as 82 million new infections occurring worldwide each year. While not…
Promising Clinical Trial Results Suggest a Path Forward in Treating DMD
Duchenne muscular dystrophy (DMD) devastates young lives. This progressive disease, stemming from mutations in the gene that encodes the protein dystrophin, weakens muscles and…

Promising Clinical Trial Results Suggest a Path Forward in Treating DMD
November 18, 2024
Duchenne muscular dystrophy (DMD) devastates young lives. This progressive disease, stemming from mutations in the gene that encodes the protein dystrophin, weakens muscles and…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…